This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer | MicrobiomeTrials
← Back to trials NCT06900595
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-02-22Est. Completion: 2029-06-02
Enrollment target: 48 participantsLocations UC San Diego Moores Cancer Center, La Jolla, California, United States Valley Children's Hospital, Madera, California, United States UCHealth University of Colorado Hospital, Aurora, Colorado, United States Lurie Children's Hospital-Chicago, Chicago, Illinois, United States Northwestern University, Chicago, Illinois, United States Carle at The Riverfront, Danville, Illinois, United States Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States Carle Physician Group-Effingham, Effingham, Illinois, United States Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States Carle BroMenn Medical Center, Normal, Illinois, United States Carle Cancer Institute Normal, Normal, Illinois, United States Other microbiome trials you might be interested in Locally Advanced Adrenal Cortex Carcinoma Adrenal Cortical Carcinoma Stage III Adrenal Cortex Carcinoma Stage IV Adrenal Cortex Carcinoma AJCC v8 Unresectable Adrenal Cortex Carcinoma
This phase II trial tests how well cabozantinib in combination with pembrolizumab works in treating patients with adreno…
Atlanta, United States Est. completion Dec 16, 2027
Adrenocortical Carcinoma Pheochromocytoma
Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States
Northwestern Medicine Orland Park, Orland Park, Illinois, United States
Memorial Hospital East, Shiloh, Illinois, United States
Carle Cancer Center, Urbana, Illinois, United States
Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States
Saint Anthony Regional Hospital, Carroll, Iowa, United States
UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States
Iowa Methodist Medical Center, Des Moines, Iowa, United States
UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States
Broadlawns Medical Center, Des Moines, Iowa, United States
Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States
UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States
UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
CoxHealth South Hospital, Springfield, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Siteman Cancer Center-South County, St Louis, Missouri, United States
Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States
Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Memorial Sloan Kettering Commack, Commack, New York, United States
Memorial Sloan Kettering Westchester, Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Duke Cancer Center Cary, Cary, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
Duke Cancer Center Raleigh, Raleigh, North Carolina, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States
Prisma Health Richland Hospital, Columbia, South Carolina, United States
Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States
BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States
Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States
Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States
Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States
Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States
Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States
Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Dell Children's Medical Center of Central Texas, Austin, Texas, United States
Parkland Memorial Hospital, Dallas, Texas, United States
UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States
UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States
Children's Hospital of San Antonio, San Antonio, Texas, United States
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States
VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
University of Washington Medical Center - Montlake, Seattle, Washington, United States Paraganglioma
This is a multicenter, Phase 1/2, First-In-Human study to assess the safety, tolerability, immunogenicity, and prelimina…
Houston, United States Completed Oct 2, 2024